Ever Source Wealth Advisors, LLC Tg Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 400 shares of TGTX stock, worth $16,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 397
0.76%
Holding current value
$16,080
Previous $9,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TGTX
# of Institutions
372Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$627 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$458 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$370 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$128 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$112 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.84B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...